Cutaneous lymphatic sporotrichosis.

dc.contributor.authorAnandi, Ven_US
dc.contributor.authorKurien, Ten_US
dc.contributor.authorJacob, Men_US
dc.contributor.authorKoshi, Gen_US
dc.date.accessioned1994-01-01en_US
dc.date.accessioned2009-05-29T10:55:17Z
dc.date.available1994-01-01en_US
dc.date.available2009-05-29T10:55:17Z
dc.date.issued1994-01-01en_US
dc.description.abstractThe first case of cutaneous lymphatic sporotrichosis from Nagaland and a case of cutaneous sporotrichosis from Kerala who had acquired infection from Assam are reported. The diagnosis in both cases were established by isolating Sporothrix schenckii from multiple cutaneous lesions. The dimorphic nature of fungus was established in vitro by demonstrating the mycelial phase at 25-30 degrees C and yeast phase at 37 degrees C and pathogenicity to white mice. Both the patients were successfully treated with oral administration of potassium iodide for 3 months.en_US
dc.description.affiliationDepartment of Microbiology, Christian Medical College & Hospital, Vellore, South India.en_US
dc.identifier.citationAnandi V, Kurien T, Jacob M, Koshi G. Cutaneous lymphatic sporotrichosis. Indian Journal of Pathology & Microbiology. 1994 Jan; 37(1): 97-100en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/72956
dc.language.isoengen_US
dc.source.urihttps://www.ijpmonline.orgen_US
dc.subject.meshAdulten_US
dc.subject.meshHumansen_US
dc.subject.meshLymphatic Diseases --microbiologyen_US
dc.subject.meshMaleen_US
dc.subject.meshSporotrichosis --drug therapyen_US
dc.titleCutaneous lymphatic sporotrichosis.en_US
dc.typeCase Reportsen_US
dc.typeJournal Articleen_US
Files
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.79 KB
Format:
Plain Text
Description: